| Literature DB >> 30065946 |
Jianguo Qiu1, Ming Li1.
Abstract
BACKGROUND: It is now established that prophylactic drainage is not needed after laparoscopic cholecystectomy (LC) for chronic calculous cholecystitis. However, the benefit of drains versus their potential harm for acute calculous cholecystitis (ACC) following laparoscopic LC has been questioned. Therefore, we conducted a comparative study to assess the need for drainage.Entities:
Mesh:
Year: 2018 PMID: 30065946 PMCID: PMC6051323 DOI: 10.1155/2018/8436749
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flowchart of patient recruitment.
Clinical data and preoperative laboratory examination.
|
|
|
|
|
|---|---|---|---|
| Age ( years) | 45±12 | 43±14 | 0.44 |
| Sex (M:F) | 45/51 | 50/56 | 0.23 |
| Body wight (kg/m2) | 23.2±2.4 | 24.5±2.2 | 0.17 |
| ASA status (I/II/III) | 55/40/11 | 50/42/14 | 0.26 |
| Previous biliary symptoms (n, %) | 78 (73.6%) | 80 (75.5%) | 0.32 |
| Duration of acute symptoms (h) | 24.5±19.5 | 25.2±20.4 | 0.29 |
| Duration of symptoms >3 days (n, %) | 67 (63.2%) | 70 (66.1%) | 0.34 |
| Previous abdominal surgery (n, %) | 18 (16.9%) | 15 (14.1%) | 0.22 |
| Fever > 37.5C (n, %) | 75(70.7%) | 77(73.3%) | 0.19 |
| Leukocyte count > 10X 109/L (n, %) | 76(71.7%) | 72(67.9%) | 0.24 |
| Laboratory examination | |||
| Total bilirubin (umol/L) | 21.7±3.5 | 22.5±4.8 | 0.15 |
| Aspartate transaminase (U/l) | 38.2±11.5 | 35.7±10.4 | 0.22 |
| Alanine transaminase (U/l) | 33.4±9.3 | 31.8±10.6 | 0.18 |
| Alkaline phosphatase (IU/l) | 110±23.7 | 100.5±25.1 | 0.14 |
Mann–Whitney U for continuous variables, and the categorical variables were analyzed by the χ2 test or continuity correction method.
Ultrasound findings for the patients on admission.
|
|
|
|
|
|---|---|---|---|
| Thickened gallbladder (n, %) | 63 (60.3%) | 59 (55.7%) | 0.11 |
| Edematous gallbladder (n, %) | 90 (84.9%) | 85 (80.2%) | 0.24 |
| Distended gallbladder (n, %) | 88 (83.1%) | 86 (81.1%) | 0.28 |
| Presence of gallstones (n, %) | 96 (90.6%) | 97 (91.5%) | 0.32 |
| USG Murphy,s sign positive(n, %) | 64 (60.4%) | 58 (54.7%) | 0.27 |
| Pericholecystic fluid (n, %) | 22 (20.7%) | 14 (13.2%) | 0.01 |
| Cyst size (cm) | 10.5±3.3 | 9.7±3.1 | 0.21 |
USG: Ultrasonography; Mann-Whitney U for continuous variables, and the categorical variables were analyzed by the χ2 test or continuity correction method.
Postoperative complication according to Clavien-Dindo classification [11].
|
|
|
|
|
|---|---|---|---|
| Total complications | 16 | 15 | 0.15 |
| No. patients with complications (n, %) | 12 (11.3%) | 14 (13.2%) | 0.16 |
| Bile leak (grade IIIa) | 2 | 1 | 0.22 |
| Fluid collection (grade I) | 7 | 9 | 0.24 |
| Bile duct injury (grade IIIa) | 0 | 0 | 0.23 |
| Pulmonary inflammation (grade II) | 2 | 3 | 0.16 |
| Incision hernia(grade II) | 2 | 1 | 0.21 |
| Bleeding (grade IIIa) | 1 | 0 | 0.35 |
| Wound infection(grade II) | 2 | 1 | 0.21 |
According to Clavien-Dindo classification of surgical complications. Grade 1 complications required no surgical or medicinal treatment; Grade 2 complications required medicinal therapy; Grade 3 complications required surgical, endoscopic, or radiologic treatment. Grades 1 and 2 were considered as minor complications, whereas Grades 3-5 were considered as major complications.
Postoperative pain score and cosmetic satisfaction results.
|
|
|
|
|
|---|---|---|---|
| Early VAS pain score | |||
| Immediate | 8.8±0.6 | 5.5±04 | < 0.001 |
| 6 hours | 7.5±0.8 | 4.5±0.3 | < 0.001 |
| 12 hours | 6.8±0.5 | 4.0±0.5 | < 0.001 |
| 24 hours | 4.7±0.6 | 3.1±0.4 | 0.02 |
| 48 hours | 4.5±0.4 | 2.5±0.2 | 0.03 |
| Late VAS pain score | |||
| 72 hours | 2.5±0.3 | 1.9±0.3 | 0.32 |
| 1 week | 2.0±0.2 | 1.5±0.2 | 0.44 |
| Cosmetic score | 7.4±2.4 | 7.9±2.1 | 0.37 |
VAS: Visual Analogue Scale; Mann–Whitney U test.
Perioperative outcomes.
|
|
|
|
|
|---|---|---|---|
| Modification of the operative technique (n, %) | 24(22.6%) | 26 (24.5%) | 0.45 |
| Operative time(minutes) | 110±15.5 | 99±10.4 | 0.04 |
| Blood loss(ml) | 75±23.5 | 70±25.8 | 0.32 |
|
|
|
| |
| Dose of analgesic (mg) | 105±50 | 75±25 | 0.02 |
| Maximum gallstone size (cm) | 2.0±1.1 | 1.9±1.3 | 0.55 |
| Time to resume normal activity (days) | 2.4±1.0 | 2.0±0.8 | 0.03 |
| Hospital stay (days) | 3.5±1.5 | 3.0±1.4 | 0.04 |
Mann–Whitney U for continuous variables, and the categorical variables were analyzed by the χ2 test or continuity correction method.